Bonesupport Holding AB (publ) (2B4.F)
EUR 28.02
(-1.06%)
EUR 28.02
(-1.06%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 13.93 Million SEK | 133.13% |
| 2022 | -5.99 Million SEK | 27.48% |
| 2021 | -8.25 Million SEK | 14.61% |
| 2020 | -9.67 Million SEK | 35.91% |
| 2019 | -15.09 Million EUR | 13.22% |
| 2018 | -17.39 Million EUR | -73.54% |
| 2017 | -10.02 Million EUR | -6.26% |
| 2016 | -9.43 Million EUR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 28.67 Million EUR | -7.97% |
| 2024 Q3 | 40.96 Million SEK | 37.85% |
| 2024 Q1 | 2.21 Million SEK | 768.95% |
| 2023 FY | 1.98 Million SEK | 133.13% |
| 2023 Q4 | 332.29 Thousand SEK | -75.2% |
| 2023 Q1 | 125.55 Thousand SEK | 108.5% |
| 2023 Q2 | 129.04 Thousand SEK | 2.78% |
| 2023 Q3 | 1.34 Million SEK | 938.39% |
| 2022 Q2 | -1.74 Million EUR | -6.88% |
| 2022 FY | -5.99 Million SEK | 27.48% |
| 2022 Q4 | -1.47 Million EUR | 7.0% |
| 2022 Q3 | -1.58 Million EUR | 9.15% |
| 2022 Q1 | -1.63 Million EUR | 30.65% |
| 2021 Q4 | -2.35 Million EUR | 0.0% |
| 2021 FY | -8.25 Million SEK | 14.61% |
| 2020 FY | -9.67 Million SEK | 35.91% |
| 2019 FY | -15.09 Million EUR | 13.22% |
| 2018 FY | -17.39 Million EUR | -73.54% |
| 2017 FY | -10.02 Million EUR | -6.26% |
| 2016 FY | -9.43 Million EUR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| SCHOTT Pharma AG & Co. KGaA | 192.38 Million EUR | 92.759% |
| Carl Zeiss Meditec AG | 327.13 Million EUR | 95.742% |
| Fielmann Aktiengesellschaft | 286.54 Million EUR | 95.139% |
| Gerresheimer AG | 213.39 Million EUR | 93.472% |
| Sartorius Aktiengesellschaft | 543.2 Million EUR | 97.436% |
| Sartorius Aktiengesellschaft | 543.2 Million EUR | 97.436% |